Meta-Cognitive Therapy in Drug-Resistant Patients with Obsessive - Compulsive Disorder: Case Report

Introduction and Aim: A significant ratio of people who suffer from Obsessive-Compulsive Disorder (OCD) do not respond well to common drugs and psychological treatments. The treatment gap increases the chronicity of the disorder and develops morbidity in social functioning, employment, and costs imposed to society. The purpose of the present study was to assess the role of Well's metacognitive model in reducing OCD symptoms and rehabilitation in the patients.
The current study is a single case study carried out in 10 sessions on a drug-resistant patient with one, three, and six month follow-ups. The tools were Structured Clinical Interview (SCID-I), Yale Brown Obsessive-Compulsive Scale (Y-BOCS), Beck Depression Scale (BDI-II), the Scale of Mental Distress (SUDs), Metacognition Questionnaire (MCQ-30), and World Health Organization's Disability Scale (WHODAS 2.0). To analyze the data, diagrams were used and the rate of recovery was calculated.
Test scores, from pre-test to post-test for (Y-BOCS) intensity scale was reduced from 36 to 8 (recovery rate: 77%). Also, the rate of depression, mental distress, and disability of patient had a significant reduction.
The meta-cognitive therapy which insists on the form of thoughts and the relationship with intrusions can be an alternative choice for drug-resistant patients with OCD and they will benefit from its therapeutic effects even in the follow-up stages.